CTIM-19. MOLECULAR AND GENETIC DETERMINANTS OF RESPONSE TO PD-1 BLOCKADE IN RECURRENT GLIOBLASTOMA PATIENTS

Despite immune checkpoint inhibitors having success in several other tumor types, many glioblastoma (GBM) patients fail to respond or maintain a sustained response. Work published by our group (Cloughesy et al, 2019) demonstrated that relative to adjuvant programmed cell death-1 (PD-1) blockade, neo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Prins, Robert, Galvez, Mildred, Amouzgar, Meelad, Campbell, Katie, Wells, Daniel, Bayless, Nicholas, Everson, Richard, Cloughesy, Timothy
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Clinical Trials: Immunologic
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650425/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.153
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars